Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods
about
Microscopic-observation drug-susceptibility assay for the diagnosis of TBDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountryPerformance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008Comparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.The future of molecular diagnostics for drug-resistant tuberculosis.Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsPhenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Diagnostic accuracy of a molecular drug susceptibility testing method for the antituberculosis drug ethambutol: a systematic review and meta-analysisSuccessful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosisDetection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping.Rifampin drug resistance tests for tuberculosis: challenging the gold standard.Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugsEthambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates.Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance.An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.Identification of Mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of PCR-electrospray ionization mass spectrometry.Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United StatesComparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs.Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis.Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system.embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.Fluoromycobacteriophages Can Detect Viable and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum CollectionSTUDY OF PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF MYCOBACTERIUM TUBERCULOSIS ISOLATES RESISTANT TO BOTH ISONIAZID AND ETHAMBUTOL
P2860
Q24683727-35EF2A92-DE84-4298-BC76-F41A3121D239Q28551469-7E730A2A-8C6D-4C90-A5CB-85225C031F84Q30224757-5B6D9FEC-DC16-495D-9580-07380AD85585Q30276393-FDFD58DA-DD3E-40F6-B1F2-06A6C1EAA488Q30455525-65B9B14D-7346-49D4-A098-D5EAB0647C3AQ31119394-C134D910-85EC-41FB-BC32-22D739B6A9B8Q33559021-A094504B-22BD-42BA-B9F1-29D8E2CC67ADQ33596103-EDE873B7-1E01-41A1-9705-549367377B69Q33836636-A5F47A9E-F8AA-436F-97F1-0377098F59EDQ34058789-446716BC-67DA-4219-9CD9-A29FE96915E9Q34874579-FB92CA7C-AF50-4108-A59A-4EA1ED9EF1CDQ34933405-76CE78F5-6FD0-43BC-AD1D-BC8C770378F2Q35204773-264EFA81-2A77-4523-94CD-E2A60046AD22Q36022970-3A67C541-7AFE-4741-91D9-1234BB6F3D59Q36247548-EB0D7AB7-65E2-4C99-991E-54D5722D44DEQ36359595-0D264594-B24F-42F9-AE9B-24A7AE7B828AQ36994443-33122C05-55EE-470A-8AA1-97E11AE5C1BBQ37036190-A77AD9BC-4136-4C36-82CC-96E960200CDFQ37115785-183B5C8D-0417-49C0-A6D9-2F347F049670Q37544293-2652A2B8-FB1E-4F81-826B-A21E8E692F62Q37546295-3E504815-68C1-471C-B563-14AAFB187A5CQ37694594-41D4492B-EBF9-41E4-93A0-AC9C7C779CE0Q37799461-DD91376E-EBCE-4ED9-A250-0A256209861EQ38545953-49A67D3E-265B-47E6-985F-7B62DB5B0BEAQ39549707-3B2F46DE-1CBB-4314-974A-516F9F2797C9Q39632553-679063D8-B08B-4BBC-9714-FF2B37188E6FQ41824901-68EB6D51-4960-4789-92C7-E7436E73BE22Q41867988-B6AEA634-FE52-48CA-8AA0-462AE877D1EBQ42577091-8312D4F5-AA5C-4270-B551-39875C3F8E78Q42939891-7A0D4BC4-1F40-4361-B61D-D8A74292A3FAQ43193831-5761ACBC-1499-46DE-82B7-FE6EA9702D99Q44309966-C775178C-F79A-401F-9B72-2D952769BFDFQ44640673-F4A2EAED-8940-4CF0-98DA-E8CD8DEBB676Q46639370-1305D6F3-DB70-4B40-86FC-218A13A9F976Q47632774-5098B6EE-8E99-4987-B904-75A8B44E67ECQ53221993-C892DA62-61EC-43B4-BDD0-1D97B37AA201Q55451060-1E345473-E55F-413D-A893-B924D6F4CD62Q56395657-71CD888E-20DE-4D25-A136-A8B78BC75C3EQ57253059-529AA9E2-0116-4E2A-AAAF-A3679E618BEE
P2860
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Multicenter evaluation of etha ...... ortion and radiometric methods
@en
Multicenter evaluation of etha ...... rtion and radiometric methods.
@nl
type
label
Multicenter evaluation of etha ...... ortion and radiometric methods
@en
Multicenter evaluation of etha ...... rtion and radiometric methods.
@nl
prefLabel
Multicenter evaluation of etha ...... ortion and radiometric methods
@en
Multicenter evaluation of etha ...... rtion and radiometric methods.
@nl
P2093
P2860
P1476
Multicenter evaluation of etha ...... ortion and radiometric methods
@en
P2093
Metchock B
Ridderhof J
Robinson-Dunn B
Sloutsky A
Washabaugh G
P2860
P304
P356
10.1128/JCM.40.11.3976-3979.2002
P407
P577
2002-11-01T00:00:00Z